CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 80 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02610751
NCT02610751N/ACompleted

Maternal Smoking During Pregnancy and Female Fetal Testosterone Levels

TriHealth Inc.·observational·Posted Nov 20, 2015·Updated Aug 28, 2019

In Brief

An observational study for Smoking. Completed, enrolled 80 participants across 2 sites.

Detailed Summary

* The investigators hope their study will answer the question of whether or not fetal testosterone levels are increased in female newborns exposed to nicotine as a result of maternal smoking during pregnancy. Secondarily they plan to also evaluate maternal cotinine and testosterone levels and newborn anogenital distance, second digit to fourth digit (2D:4D) finger length ratio, newborn length and birth weight. * The investigators hope by performing this study, they will help to uncover the effect of tobacco exposure in utero on human female fetal testosterone levels, thus improving the counseling for tobacco use in pregnancy.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedNov 20, 2015
Enrollment StartJan 1, 2016
Primary CompletionAug 26, 2019
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 10.6 years ago